<DOC>
	<DOCNO>NCT00209599</DOCNO>
	<brief_summary>This study design demonstrate AQUAVAN® effective provide adequate sedation elderly patient undergo colonoscopy well assess safety profile AQUAVAN versus midazolam . Prior procedure , patient receive fentanyl citrate pain management follow five minute later AQUAVAN® Injection sedation . Throughout procedure , study personnel assess patient 's vital sign depth sedation . After procedure , patient , physician , evaluator ask complete satisfaction survey .</brief_summary>
	<brief_title>A Study AQUAVAN® Injection Versus Midazolam HCl Sedation Elderly Patients Undergoing Elective Colonoscopy</brief_title>
	<detailed_description>This randomize , open-label study design ass safety efficacy AQUAVAN ® Injection versus midazolam HCl follow pretreatment analgesic , fentanyl citrate injection , produce sedation elderly patient undergo colonoscopy . Following completion preprocedure sedation assessment , patient randomly assign 1 2 i.v . treatment group 4:1 ( AQUAVAN® . Injection : midazolam HCl ) allocation ratio . To ensure distribution age obtain , enrollment stratify 2 equal-size group age ( &gt; 65 &lt; 72 year age &gt; 72 year age ) . Randomization stratify site within age group . All patient receive fentanyl citrate injection analgesic pretreatment . Supplemental dos fentanyl citrate injection may administer patient report pain inadequate analgesia present demonstrate increased heart rate and/or blood pressure presence adequate sedation . At time fentanyl citrate injection administer increase sedation level . AQUAVAN® . Injection midazolam HCl administer induce state adequate sedation , define Modified Observer 's Assessment Alertness/Sedation ( OAA/S ) score 4 less . Supplemental dos administer increase depth duration sedation . Supplemental dos administer Modified OAA/S score 2 less purposeful response stimulation . The depth sedation measure Modified OAA/S scale , validated measure . Patient Investigator assessment use confirm depth sedation provide met goal sedation , reduction anxiety reduce awareness .</detailed_description>
	<mesh_term>Fospropofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Patient provide signed/dated Informed Consent HIPAA authorization receive full explanation extent nature study . 2 . Patient 65 year age time screen . 3 . Patient meet ASA Physical Status Classification I III . 1 . Patient history allergic reaction hypersensitivity anesthetic agent , narcotic , benzodiazepine . 2 . Patient meet nil per o ( NPO ) status per ASA Guideline institution 's guideline . 3 . Patient condition ( ) , opinion Investigator , could interfere appropriate airway management . 4 . Patient history mental visual impairment would permit successful measurement cognitive evaluation . 5 . Patient unwilling adhere pre postprocedural instruction . 6 . The use fentanyl midazolam contraindicate patient . 7 . Patient participate investigational drug study within 1 month prior study start . 8 . Patient prior exposure AQUAVAN .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Colonoscopy</keyword>
	<keyword>Seadation</keyword>
</DOC>